• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张症患者死亡率相关因素分析

Analysis of the factors related to mortality in patients with bronchiectasis.

作者信息

Onen Zeynep Pinar, Gulbay Banu Eris, Sen Elif, Yildiz Oznur Akkoca, Saryal Sevgi, Acican Turan, Karabiyikoglu Gülseren

机构信息

Department of Pulmonary Diseases, School of Medicine, Ankara University, Ankara, Turkey.

出版信息

Respir Med. 2007 Jul;101(7):1390-7. doi: 10.1016/j.rmed.2007.02.002. Epub 2007 Mar 19.

DOI:10.1016/j.rmed.2007.02.002
PMID:17374480
Abstract

BACKGROUND

Bronchiectasis is a common disabling but rarely fatal disease. However the long-term prognosis and risk factors for mortality are not well known.

OBJECTIVE

The aim of this study was to determine prospectively the survival and predictive factors of mortality in patients with bronchiectasis, during 4-year follow-up.

PATIENTS AND METHODS

From September 2000 to January 2005 survival of bronchiectasis (as evaluated by computed tomography) and predictors of mortality were assessed in 98 outpatients. Fifty-one of the patients had self-reported history of pulmonary infection including tuberculosis. Baseline data, reevaluated in every single year according to scheduled visits.

RESULTS

The mean age was 61+/-10 and 74% of the patients were female. In total, 16 patients (16.3%) died; mean survival time was 44.06+/-1.6 months. The survival rates were 97%, 89%, 76%, 58% at 1, 2, 3 and 4 years, respectively. Cox proportional hazard model revealed that long-term mortality was significantly associated with age, body mass index (BMI), Medical Research Council (MRC) dyspnea scale, vaccination, radiographic extent, hypoxemia, hypercapnia and functional parameters. However, MRC and BMI had more significant effects on the mortality than the functional parameters.

CONCLUSIONS

These results suggest that high BMI, regular vaccination and scheduled visits may have beneficial effects on the survival of bronchiectasis. Besides, presence of hypoxemia, hypercapnia, dyspnea level and radiographic extent were more closely correlated with mortality.

摘要

背景

支气管扩张是一种常见的致残但很少致命的疾病。然而,其长期预后和死亡风险因素尚不明确。

目的

本研究旨在前瞻性地确定支气管扩张患者在4年随访期间的生存率和死亡预测因素。

患者与方法

2000年9月至2005年1月,对98例门诊患者评估支气管扩张的生存率(通过计算机断层扫描评估)和死亡预测因素。其中51例患者有自我报告的肺部感染病史,包括结核病。根据预定随访每年重新评估基线数据。

结果

平均年龄为61±10岁,74%的患者为女性。共有16例患者(16.3%)死亡;平均生存时间为44.06±1.6个月。1年、2年、3年和4年的生存率分别为97%、89%、76%、58%。Cox比例风险模型显示,长期死亡率与年龄、体重指数(BMI)、医学研究委员会(MRC)呼吸困难量表、疫苗接种、影像学范围、低氧血症、高碳酸血症和功能参数显著相关。然而,MRC和BMI对死亡率的影响比功能参数更显著。

结论

这些结果表明,高BMI、定期疫苗接种和定期随访可能对支气管扩张患者的生存有有益影响。此外,低氧血症、高碳酸血症、呼吸困难程度和影像学范围与死亡率的相关性更强。

相似文献

1
Analysis of the factors related to mortality in patients with bronchiectasis.支气管扩张症患者死亡率相关因素分析
Respir Med. 2007 Jul;101(7):1390-7. doi: 10.1016/j.rmed.2007.02.002. Epub 2007 Mar 19.
2
Emphysema is an independent risk factor for 5-year mortality in patients with bronchiectasis.肺气肿是支气管扩张症患者5年死亡率的独立危险因素。
Clin Respir J. 2017 Nov;11(6):887-894. doi: 10.1111/crj.12432. Epub 2016 Jan 11.
3
Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症患者体重指数与疾病严重程度及预后的关系
Braz J Med Biol Res. 2015 Aug;48(8):715-24. doi: 10.1590/1414-431X20154135. Epub 2015 Jul 10.
4
Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.支气管扩张症患者中与肺动脉高压及长期生存相关的因素。
Respir Med. 2016 Oct;119:109-114. doi: 10.1016/j.rmed.2016.08.027. Epub 2016 Aug 30.
5
Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis.支气管扩张症中肺功能、呼吸困难评分与肺扩张的分离
Respir Med. 2007 Nov;101(11):2248-53. doi: 10.1016/j.rmed.2007.06.028. Epub 2007 Aug 14.
6
Predictors of long-term survival in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者长期生存的预测因素
Saudi Med J. 2006 Dec;27(12):1866-72.
7
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival.支气管扩张症的死亡率:一项评估影响生存因素的长期研究。
Eur Respir J. 2009 Oct;34(4):843-9. doi: 10.1183/09031936.00003709. Epub 2009 Apr 8.
8
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study.利用支气管扩张严重指数和 FACED 评分预测支气管扩张症患者的死亡率:一项 19 年的队列研究。
Eur Respir J. 2016 Feb;47(2):482-9. doi: 10.1183/13993003.01312-2015. Epub 2015 Nov 19.
9
Surgical management of bronchiectasis: a collective review of 339 patients with long-term follow-up.支气管扩张症的外科治疗:339例患者的长期随访综合回顾
Thorac Cardiovasc Surg. 2011 Dec;59(8):479-83. doi: 10.1055/s-0030-1270701. Epub 2011 Mar 21.
10
Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis.住院支气管扩张症急性加重患者死亡的预测因素。
Respir Med. 2010 Jun;104(6):816-21. doi: 10.1016/j.rmed.2009.11.021. Epub 2010 Apr 3.

引用本文的文献

1
Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis.与支气管扩张症相关的真实世界疾病负担、死亡率及医疗资源利用情况。
Chron Respir Dis. 2025 Jan-Dec;22:14799731241310897. doi: 10.1177/14799731241310897.
2
Respiratory Pathology and Cardiovascular Diseases: A Scoping Review.呼吸病理学与心血管疾病:一项范围综述
Open Respir Arch. 2024 Nov 23;7(1):100392. doi: 10.1016/j.opresp.2024.100392. eCollection 2025 Jan-Mar.
3
Epidemiology of bronchiectasis.支气管扩张症的流行病学。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0091-2024. Print 2024 Oct.
4
Biomarkers in bronchiectasis.支气管扩张症的生物标志物。
Eur Respir Rev. 2024 Jul 3;33(173). doi: 10.1183/16000617.0234-2023. Print 2024 Jul.
5
Factors influencing survival and mortality among adult Aboriginal Australians with bronchiectasis-A 10-year retrospective study.影响成年澳大利亚原住民支气管扩张症患者生存和死亡的因素——一项10年回顾性研究。
Front Med (Lausanne). 2024 May 7;11:1366037. doi: 10.3389/fmed.2024.1366037. eCollection 2024.
6
Bronchiectasis in Türkiye: Data from a Multicenter Registry (Turkish Adult Bronchiectasis Database).土耳其的支气管扩张症:来自多中心注册研究的数据(土耳其成人支气管扩张症数据库)
Balkan Med J. 2024 May 3;41(3):206-212. doi: 10.4274/balkanmedj.galenos.2024.2023-12-57.
7
The clinical characteristics of non-cystic fibrosis bronchiectasis patients with positive serum tumor markers: a retrospective study.非囊性纤维化支气管扩张症患者血清肿瘤标志物阳性的临床特征:一项回顾性研究。
BMC Pulm Med. 2024 Jan 8;24(1):20. doi: 10.1186/s12890-023-02816-7.
8
The relation between inspiratory muscle strength and bacterial colonization and other clinical factors in patients with non-cystic fibrosis bronchiectasis.支气管扩张症非囊性纤维化患者吸气肌力量与细菌定植及其他临床因素的关系。
Tuberk Toraks. 2023 Jun;71(2):113-122. doi: 10.5578/tt.20239914.
9
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan.非结核分枝杆菌病与支气管扩张症的流行病学特征:基于日本1970年至2015年全国死亡率统计数据的比较研究
ERJ Open Res. 2023 Feb 20;9(1). doi: 10.1183/23120541.00424-2022. eCollection 2023 Jan.
10
Cardiovascular and cerebrovascular-associated mortality in patients with preceding bronchiectasis exacerbation.支气管扩张症加重患者的心血管和脑血管相关死亡率。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221144206. doi: 10.1177/17534666221144206.